Table 2.
Released cues | Effective concentrations | Toxic concentrations |
---|---|---|
Metal ions | ||
Co2+ |
25 × 10−6
m for HIF stabiliztion in neuroblastoma cells;119
3–12 ppm for HIF activation in endothelial cells77 |
1–2 × 10−3 m (acute toxic concentrtaion to lung cells120) |
Cd2+ | 7 × 10−6 m for HIF stabiliztion in neuroblastoma cells119 | 15 × 10−6 m (LD50 for pituitary cells81) |
Cu2+ | 100–200 × 10−6 m for HIF stabiliztion in hepatoma cells121 | ≈200 × 10−6 m (IC50 for hepatoma cells121) |
Regulatory metabolite | ||
Citrate | 100–2000 × 10−6 m for promoted osteo‐phenotype progression of hMSCs80 |
37.3 × 10−3
m (EC50 for hMSCs86); 10.9 × 10−3 m (EC50 for MG6386); 10.5 × 10−3 m (EC50 for 3T386); |
Inorganic phosphate | 5 × 10−3 m for induced osteogenic differentiation of hMSCs19 | Not available |
Lactate | 0.06–0.17 mg mL−1 for radical scavenging92 | 20 × 10−3 m (critical toxic concentration for hMSCs122) |